Back to Search
ALFREDO VITERI, M.D.
M.D.
Specialist
NPI: 1518968395Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
D7799(TX)
Research & Publications (8)
Efficacy and safety of cisplatin and capecitabine in combination as first line treatment for unselected patients with advanced gastric cancer.
PMID 17450479·Acta Oncol·2007
8-other
Oxaliplatin overdosage successfully recovered with mild toxicities.
PMID 16864179·Acta Oncol·2006
5-case
Biweekly administration of cisplatin/gemcitabine in advanced nonsmall cell lung cancer.
PMID 16199991·Am J Clin Oncol·2005
3-trial
Acrokeratosis paraneoplastica (Bazex syndrome) preceeding the diagnosis of metastatic squamous cell carcinoma of the esophagus.
PMID 15793535·J Am Acad Dermatol·2005
5-case
A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer.
PMID 14621068·Int J Clin Pharmacol Res·2003
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 902 FROSTWOOD DR
HOUSTON, TX 77024 - Phone
- (713) 984-2770
Quick Facts
- NPI
- 1518968395
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile